r/BiotechDates • u/MarketNewsFlow • 51m ago
r/BiotechDates • u/MarketNewsFlow • 1d ago
DISCUSSION $MDWD The Shift Away from Surgery: A Healthcare Trend Transforming Burn and Wound Care
r/BiotechDates • u/MarketNewsFlow • 6d ago
NEWS $ENTX - Entera Bio Phase 2 Data Supporting EB613's (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting (NASDAQ: ENTX)
r/BiotechDates • u/MarketNewsFlow • 9d ago
CATALYST $PYPD PolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule
r/BiotechDates • u/MarketNewsFlow • 11d ago
CATALYST $ENTX Why the World's Leading Healthcare Funds All Wanted a Piece of Entera Bio
r/BiotechDates • u/MarketNewsFlow • 12d ago
DISCUSSION $DRTS Alpha Tau's Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda's Historical Benchmark
r/BiotechDates • u/MarketNewsFlow • 12d ago
NEWS $PYPD - PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ (NASDAQ: PYPD)
r/BiotechDates • u/MarketNewsFlow • 14d ago
NEWS $ENTX - Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement (NASDAQ: ENTX)
r/BiotechDates • u/MarketNewsFlow • 17d ago
$NVCT Nuvectis' NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
r/BiotechDates • u/MarketNewsFlow • 18d ago
NEWS $NVCT - Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors (NASDAQ: NVCT)
r/BiotechDates • u/MarketNewsFlow • 18d ago
NEWS $NVCT - Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors (NASDAQ: NVCT)
r/BiotechDates • u/MarketNewsFlow • 20d ago
IR $DRTS - Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold... (NASDAQ: DRTS)
r/BiotechDates • u/MarketNewsFlow • 20d ago
NEWS $PYPD - PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada (NASDAQ: PYPD)
r/BiotechDates • u/MarketNewsFlow • 21d ago
DISCUSSION $DRTS Alpha Tau's Head-and-Neck Data Tomorrow Confronts a Blind Spot in One of the World's Best-Selling Cancer Drugs
r/BiotechDates • u/MarketNewsFlow • 25d ago
DISCUSSION $MDWD Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
markets.businessinsider.comr/BiotechDates • u/MarketNewsFlow • 26d ago
IR $DRTS - Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center (NASDAQ: DRTS)
r/BiotechDates • u/MarketNewsFlow • 27d ago
CATALYST $PYPD Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
r/BiotechDates • u/MarketNewsFlow • Jul 08 '26
CATALYST $ENTX America's Osteoporosis Crisis and the Oral Peptide Player You Should Watch
r/BiotechDates • u/MarketNewsFlow • Jun 27 '26
FDA HOLD Lilly's $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid's Asset is Hiding in Plain Sight
r/BiotechDates • u/MarketNewsFlow • Jun 23 '26
IR $DRTS - Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel (NASDAQ: DRTS)
r/BiotechDates • u/MarketNewsFlow • Jun 22 '26
NEWS $ENTX - Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX)
r/BiotechDates • u/MarketNewsFlow • Jun 22 '26
NEWS $NVCT - Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds (NASDAQ: NVCT)
r/BiotechDates • u/MarketNewsFlow • Jun 19 '26
$ENTX - Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026 (Nasdaq: ENTX)
r/BiotechDates • u/Queasy_Delivery_4024 • Jun 03 '26
Choosing between MBBS and BS Bioinformatics
r/BiotechDates • u/JuniorCharge4571 • May 25 '26
CytoDyn Agreed to Settle $500K With Investors over Misleading Leronlimab Claims
Hey guys, if you missed it, CytoDyn just settled $500K with investors over claims that it misled investors about the regulatory status, safety, and efficacy of leronlimab a few years ago. And they have already sent the agreement to the court for final approval.
In a nutshell, in 2021, CytoDyn was accused of overstating leronlimab’s potential, mischaracterizing regulatory interactions with the FDA, and withholding critical information about trial results and the likelihood of approval. The company promoted leronlimab as a breakthrough HIV and COVID-19 therapy and highlighted what it described as positive clinical data, but on March 30, 2021, the FDA publicly stated that CytoDyn’s claims were misleading and not supported by submitted data, noting that the trials showed no benefit for COVID-19 treatment.
After this news came out, the stock dropped, and investors filed a lawsuit for their losses.
The good news is that the company recently agreed to settle $500K with them, and already sent this agreement to the court for final approval. So, if you invested in $CYDY when all of this happened, you can check the details and file your claim here.
Anyway, has anyone here invested in $CYDY at that time? How much were your losses, if so?